What is the recommended acute and secondary management for a patient with a posterior cerebral artery infarct, including indications for intravenous alteplase, endovascular thrombectomy, antiplatelet or anticoagulant therapy, high‑intensity statin, risk‑factor control, and early rehabilitation?

Management of Posterior Cerebral Artery Infarct

Acute Reperfusion Therapy

Administer IV alteplase 0.9 mg/kg (maximum 90 mg) to eligible PCA infarct patients within 3 hours of symptom onset, and consider extending the window to 4.5-24 hours for posterior circulation strokes based on recent evidence showing superior functional outcomes. 1, 2, 3

IV Alteplase Administration

• Dosing protocol: Give 10% as IV bolus over 1 minute, then infuse remaining 90% over 60 minutes, with target door-to-needle time under 60 minutes 2
• Extended window for posterior circulation: A 2025 Chinese trial demonstrated that alteplase given 4.5-24 hours after posterior circulation stroke onset resulted in 89.6% functional independence versus 72.6% with standard care (adjusted risk ratio 1.16,95% CI 1.03-1.30), with symptomatic ICH rate of only 1.7% 3
• Critical exclusions: Blood pressure >185/110 mmHg, platelet count <100,000/mm³, INR >1.7, glucose <50 or >400 mg/dL, extensive hypodensity on CT (>1/3 MCA territory equivalent), prior stroke within 3 months, history of intracranial hemorrhage, or recent major surgery within 14 days 1, 2

Blood Pressure Management Around Alteplase

• Pre-alteplase: Reduce BP to <185/110 mmHg using labetalol 10-20 mg IV over 1-2 minutes, nicardipine infusion starting at 5 mg/h (titrate by 2.5 mg/h every 5-15 minutes, max 15 mg/h), or clevidipine 1-2 mg/h (double every 2-5 minutes, max 21 mg/h) 1, 2
• During and post-alteplase: Maintain BP ≤180/105 mmHg 1, 2
• Monitoring schedule: Every 15 minutes during infusion and for 2 hours after, every 30 minutes for next 6 hours, then hourly until 24 hours 1, 2

Endovascular Thrombectomy Considerations

• Indications for PCA territory: While guidelines primarily address anterior circulation, consider thrombectomy for proximal PCA occlusions with significant penumbra on perfusion imaging within 6-24 hours 1, 2
• Parallel processing: If patient qualifies for both alteplase and thrombectomy, start alteplase immediately while preparing angiography suite—do not delay alteplase for imaging 2
• Imaging requirements: Obtain CT angiography immediately to identify vessel occlusion location, but do not postpone alteplase administration 2

Acute Physiologic Management

Temperature and Glucose Control

• Temperature: Monitor every 4 hours for first 48 hours; treat fever >37.5°C with antipyretics and identify infection sources 2
• Glucose: Maintain blood glucose 140-180 mg/dL; monitor regularly and avoid hypoglycemia 1, 2

Monitoring for Complications

• Neurological checks: Perform NIHSS every 15 minutes during and for 2 hours after alteplase, every 30 minutes for next 6 hours, then hourly until 24 hours 2
• Hemorrhage warning signs: Stop alteplase immediately and obtain emergent CT if severe headache, acute hypertension, nausea/vomiting, or neurological worsening occurs 2
• Symptomatic ICH management: Stop alteplase, obtain stat CT, check CBC/PT/INR/aPTT/fibrinogen, administer cryoprecipitate and tranexamic acid, consult hematology and neurosurgery 2

Secondary Prevention Strategies

Antiplatelet Therapy

Start aspirin 160-325 mg within 24-48 hours after stroke onset, but delay for 24 hours if alteplase was administered, as concurrent use increases symptomatic ICH risk from 1.6% to 4.3%. 1, 2, 4

• Dual antiplatelet therapy for minor stroke: If NIHSS <4, initiate aspirin plus clopidogrel within 12-24 hours and continue for exactly 21 days, then switch to monotherapy 4, 5, 6
• Evidence for DAPT in posterior circulation: A 2025 propensity-matched analysis showed DAPT is equally safe and effective in posterior versus anterior circulation infarcts, with 90-day ischemic event rates of 3.1% versus 2.9% respectively 6
• Avoid early antiplatelet with alteplase: Do not give aspirin or other antiplatelets within 24 hours of thrombolysis due to marked increase in symptomatic ICH 1, 2

High-Intensity Statin Therapy

Initiate atorvastatin 80 mg daily immediately for all PCA infarct patients regardless of baseline cholesterol levels, targeting LDL-C <70 mg/dL or ≥50% reduction from baseline. 4

Blood Pressure Control

• Acute phase (first 24 hours): Avoid aggressive BP lowering unless needed for alteplase eligibility or if BP >220/120 mmHg 1
• Subacute phase (after 24 hours): Begin antihypertensive therapy targeting <130/80 mmHg for most patients, or <120/80 mmHg for optimal secondary prevention 4

Anticoagulation for Cardioembolic Mechanism

• Timing: If atrial fibrillation or other cardioembolic source is identified, initiate direct oral anticoagulants (DOACs preferred over warfarin) after 4-14 days depending on infarct size 4, 5
• Small infarcts (<1.5 cm): Start anticoagulation at 3-4 days 5
• Moderate infarcts (1.5-5 cm): Start at 6-8 days 5
• Large infarcts (>5 cm): Delay until 12-14 days due to hemorrhagic transformation risk 5

Stroke Unit Care and Rehabilitation

Specialized Unit Admission

Admit all PCA infarct patients to a geographically defined stroke unit with specialized staff within 24 hours of arrival, as this reduces mortality (OR 0.76) and dependence (OR 0.80) compared to general medical wards. 2, 4

Early Mobilization and Rehabilitation

• Mobilization: Begin frequent, brief out-of-bed activity within 24 hours if no contraindications 2
• Rehabilitation assessment: Initiate physical therapy, occupational therapy, and speech/swallowing evaluation within 48 hours of admission 2, 4
• Swallowing screen: Perform on day of admission before any oral intake 2

Management of Posterior Circulation-Specific Complications

Cerebellar Edema and Brainstem Compression

• Monitoring: PCA infarcts involving thalamus or occipital lobe require close observation for cerebral edema peaking at 3-5 days 4
• Avoid corticosteroids: Do not use steroids for cerebral edema 2
• Surgical intervention: For large cerebellar infarctions with brainstem compression, decompressive surgery may be life-saving 2

Seizure Management

• Treatment approach: Treat new-onset seizures with short-acting anticonvulsants 1
• Prophylaxis: Do not use prophylactic anticonvulsants in patients without seizures 1, 2

DVT Prophylaxis

Administer subcutaneous unfractionated heparin 5000 IU twice daily or low-molecular-weight heparin for immobilized patients to prevent deep vein thrombosis. 4

Critical Pitfalls to Avoid

• Time delays: Every 30-minute delay in recanalization decreases good functional outcome by 8-14%—speed is paramount 2
• Premature antiplatelet use: Aspirin given concurrently with alteplase increases symptomatic ICH risk 2.7-fold (4.3% vs 1.6%) 2
• Missing 24-hour imaging: Failure to obtain follow-up CT/MRI at 24 hours before starting antiplatelets or anticoagulants increases hemorrhage risk 2
• Inadequate BP control: Poor blood pressure management before thrombolysis significantly increases symptomatic ICH risk 2
• Overlooking extended window: Do not automatically exclude posterior circulation stroke patients presenting at 4.5-24 hours from alteplase consideration, as recent evidence supports treatment in this extended window 3